Literature DB >> 32561754

Author Correction: Crohn's disease.

Giulia Roda1, Siew Chien Ng2, Paulo Gustavo Kotze3, Marjorie Argollo1, Remo Panaccione4, Antonino Spinelli5,6, Arthur Kaser7, Laurent Peyrin-Biroulet8, Silvio Danese9,10.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID： 32561754     DOI： 10.1038/s41572-020-0193-x

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN： 2056-676X            Impact factor:   52.329


  3 in total

1.  Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease.

Authors:  Anna Nemirovsky; Karny Ilan; Livnat Lerner; Liel Cohen-Lavi; Doron Schwartz; Ganit Goren; Ruslan Sergienko; Dan Greenberg; Vered Slonim-Nevo; Orly Sarid; Michael Friger; Shirley Regev; Shmuel Odes; Tomer Hertz; Alon Monsonego
Journal:  Brain Behav Immun Health       Date:  2021-12-23

2.  Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn's Disease.

Authors:  Rirong Chen; Li Li; Chao Li; Yuhan Su; Yingfan Zhang; Xiaobai Pang; Jieqi Zheng; Zhirong Zeng; Min-Hu Chen; Shenghong Zhang
Journal:  J Inflamm Res       Date:  2021-12-25

3.  Mycobacterial Hsp65 antigen delivered by invasive Lactococcus lactis reduces intestinal inflammation and fibrosis in TNBS-induced chronic colitis model.

Authors:  Vanessa Pecini da Cunha; Tatiane Melo Preisser; Mariana Passos Santana; Denise Carmona Cara Machado; Vanessa Bastos Pereira; Anderson Miyoshi
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.